Health and Aging

Memory and Cognitive Health

2013 webinar series on Alzheimer’s disease and resources

The National Institute on Aging (NIA) at the National Institutes of Health (NIH) and the Administration for Community Living (ACL) are collaborating to host a webinar series with the goals of 1) improving coordination of federal resources available to assist people with Alzheimer’s disease or other dementias and their family caregivers and 2) encouraging awareness of research participation opportunities.

Alzheimer's Disease Measurement Improvement Conference

The Division of Neuroscience partnered with the Foundation for  NIH (FNIH) to conduct a one day exploratory meeting.

NIA researchers find protein PGC-1alpha may play important role in brain health

The human brain is made up of tens of billions of neurons, brain cells that act as information messengers, transmitting and receiving chemical and electrical signals. These messages are received by branch-like cell structures called dendrites after traveling across synapses, the tiny gap between neurons. Now, researchers in NIA’s Intramural Research Program have shown in mice that a protein, PGC-1alpha, may play an important role in forming and maintaining healthy dendrites and synapses in the hippocampus--the brain region important to learning and memory.

NIH Toolbox Unveiled

 Motor, Emotion, Sensation, CognitionStandardized neurological, behavioral measures to aid clinical research

Preventing Alzheimer’s Disease: What Do We Know?

Although Alzheimer's disease currently has no cure, recent research results point toward a day when it might be possible to delay, slow down, or even prevent this devastating brain disorder. This 24-page booklet describes the latest NIA-funded research about prevention of Alzheimer's disease and age-related cognitive decline, from physical exercise and diet to social engagement and cognitive training. Also included are tips for staying healthy as you grow older.

English

NIH Toolbox for Assessment of Neurological and Behavioral Function Public Conference - "Unveiling the NIH Toolbox"

An overview of the development, testing, and use of the NIH Toolbox in biomedical research. Agenda included lectures, interactive demonstrations, and panel discussions. A large public conference was held near the end of the second year of the NIH Toolbox contract period to present to the research and practice communities the finalized, validated and normed instruments that comprise the NIH Toolbox.

Molly Wagster

301-496-9350

Experimental Alzheimer’s drug shows promise in small, early-phase clinical studies

Posiphen, a drug candidate designed and developed by researchers in the NIA’s Intramural Research Program, has been shown in three small, early studies to be well-tolerated and to reduce the generation of amyloid and tau protein—the hallmarks of Alzheimer’s disease—in older people at risk for developing the disorder.

NIH-funded research provides new clues on how ApoE4 affects Alzheimer's risk

Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear.  Now, researchers funded by the National Institutes of Health have found that in mice, having the most risky variant of ApoE damages the blood vessels that feed the brain.

Obama administration presents national plan to fight Alzheimer’s disease

Health and Human Services Secretary Kathleen Sebelius today released an ambitious national plan to fight Alzheimer’s disease. The plan was called for in the National Alzheimer’s Project Act (NAPA), which President Obama signed into law in January 2011. The National Plan to Address Alzheimer’s Disease sets forth five goals, including the development of effective prevention and treatment approaches for Alzheimer’s disease and related dementias by 2025.

Subscribe to RSS - Memory and Cognitive Health